EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice. 2014

Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
Department of Basic and Social Sciences, Albany College of Pharmacy and Health Sciences, Albany, New York, USA.

Francisella tularensis is a category A biodefence agent that causes a fatal human disease known as tularaemia. The pathogenicity of F. tularensis depends on its ability to persist inside host immune cells primarily by resisting an attack from host-generated reactive oxygen and nitrogen species (ROS/RNS). Based on the ability of F. tularensis to resist high ROS/RNS levels, we have hypothesized that additional unknown factors act in conjunction with known antioxidant defences to render ROS resistance. By screening a transposon insertion library of F. tularensis LVS in the presence of hydrogen peroxide, we have identified an oxidant-sensitive mutant in putative EmrA1 (FTL_0687) secretion protein. The results demonstrate that the emrA1 mutant is highly sensitive to oxidants and several antimicrobial agents, and exhibits diminished intramacrophage growth that can be restored to wild-type F. tularensis LVS levels by either transcomplementation, inhibition of ROS generation or infection in NADPH oxidase deficient (gp91Phox(-/-)) macrophages. The emrA1 mutant is attenuated for virulence, which is restored by infection in gp91Phox(-/-) mice. Further, EmrA1 contributes to oxidative stress resistance by affecting secretion of Francisella antioxidant enzymes SodB and KatG. This study exposes unique links between transporter activity and the antioxidant defence mechanisms of F. tularensis.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008561 Membrane Fusion The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. Fusion, Membrane,Fusions, Membrane,Membrane Fusions
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005604 Francisella tularensis The etiologic agent of TULAREMIA in man and other warm-blooded animals. Bacterium tularense,Brucella tularensis,Francisella tularense,Pasteurella tularensis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000074662 NADPH Oxidase 2 An NADPH oxidase that is expressed by PHAGOCYTES where it transfers electrons across the plasma membrane from cytosolic NADPH to molecular oxygen on the exterior. It regulates proton (H+) flux into resting phagocytes to control intracellular pH. Mutations in the CYBB gene are associated with X-LINKED CHRONIC GRANULOMATOUS DISEASE. CYBB Protein,Chronic Granulomatous Disease Protein,Cytochrome B-245 Beta Chain,GP91-PHOX Protein,NOX2 Protein,Cytochrome B 245 Beta Chain,GP91 PHOX Protein,Oxidase 2, NADPH

Related Publications

Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
April 2018, Journal of bacteriology,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
January 2012, BMC microbiology,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
October 2004, Journal of bacteriology,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
March 2004, Proceedings of the National Academy of Sciences of the United States of America,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
May 2006, Infection and immunity,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
January 2011, Frontiers in microbiology,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
October 1977, Journal of the Reticuloendothelial Society,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
January 2019, PloS one,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
May 2013, Journal of leukocyte biology,
Zhuo Ma, and Sukalyani Banik, and Harshita Rane, and Vanessa T Mora, and Seham M Rabadi, and Christopher R Doyle, and David G Thanassi, and Chandra Shekhar Bakshi, and Meenakshi Malik
May 2016, Infection and immunity,
Copied contents to your clipboard!